Title : Lovastatin reduces PEL cell survival by phosphorylating ERK1/2 that blocks the autophagic flux and engages a cross-talk with p53 to activate p21.

Pub. Date : 2021 Jul

PMID : 33987937






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Lovastatin reduces PEL cell survival by phosphorylating ERK1/2 that blocks the autophagic flux and engages a cross-talk with p53 to activate p21. Lovastatin H3 histone pseudogene 16 Homo sapiens
2 At molecular level, Lovastatin by dephosphorylating STAT3, induced ERK1/2 activation that inhibited autophagy and phosphorylated p53ser15 that in turn maintained ERK1/2 activated and up-regulated p21. Lovastatin H3 histone pseudogene 16 Homo sapiens
3 However, p21 played a pro-survival role in this setting, as its inhibition by UC2288 further reduced cell survival in PEL cells undergoing Lovastatin treatment. Lovastatin H3 histone pseudogene 16 Homo sapiens
4 In conclusion, this study suggests that Lovastatin may represent a valid therapeutic alternative against PEL cells, especially if used in combination with p21 inhibitors. Lovastatin H3 histone pseudogene 16 Homo sapiens